HO-1 neutralizes the highly cytotoxic, free radical-producing heme and has been functionally implicated in both acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) [24]. This evidence concerns the gene HMOX1 and chronic myelogenous leukemia, BCR-ABL1 positive.